Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miloje Tomasevic

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Acta Cardiologica|March 31, 2011
Stenting a myocardial bridge: a wrong decision in STEMI?Miloje Tomasevic, Miodrag Dikic, Miodrag Ostojic
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|May 8, 2020
Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety MarginGoran Koracevic, Milovan Stojanovic, Tomislav Kostic, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Anti-Inflammatory Therapy in Coronary Artery Disease: Where Do We Stand?Jelena Rakocevic, Milan Dobric, Milica Labudovic Borovic, et al.
Current Hypertension Reviews|November 4, 2025
Hypertension-Mediated Organ Damages should be Divided into Acute and ChronicGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Expert Review of Cardiovascular Therapy|April 24, 2026
Time for a new category: "acute-on-chronic" hypertensive target organ damageGoran Koraćević, Milovan Stojanovic, Dragan Simic, et al.
Kardiologia Polska|December 24, 2008
Heart failure caused by cardiac rhabdomyosarcomaMiodrag Damjanovic, Danijela Djordjevic-Radojkovic, Zoran Perisic, et al.
Current Hypertension Reviews|March 25, 2026
What is the Target Resting Heart Rate in Guidelines on Hypertension?Goran Koracevic, Milovan Stojanovic, Miloje Tomasevic, et al.
Current Vascular Pharmacology|January 24, 2025
Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular HypertrophyGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 31, 2022
A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart FailureGoran Koracevic, Zoran Perisic, Maja Stanojkovic, et al.
International Journal of Molecular Sciences|March 29, 2023
Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in FocusJelena Rakocevic, Milan Dobric, Rada Vucic, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Acta Cardiologica|March 31, 2011
Stenting a myocardial bridge: a wrong decision in STEMI?Miloje Tomasevic, Miodrag Dikic, Miodrag Ostojic
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|May 8, 2020
Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety MarginGoran Koracevic, Milovan Stojanovic, Tomislav Kostic, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Anti-Inflammatory Therapy in Coronary Artery Disease: Where Do We Stand?Jelena Rakocevic, Milan Dobric, Milica Labudovic Borovic, et al.
Current Hypertension Reviews|November 4, 2025
Hypertension-Mediated Organ Damages should be Divided into Acute and ChronicGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Expert Review of Cardiovascular Therapy|April 24, 2026
Time for a new category: "acute-on-chronic" hypertensive target organ damageGoran Koraćević, Milovan Stojanovic, Dragan Simic, et al.
Kardiologia Polska|December 24, 2008
Heart failure caused by cardiac rhabdomyosarcomaMiodrag Damjanovic, Danijela Djordjevic-Radojkovic, Zoran Perisic, et al.
Current Hypertension Reviews|March 25, 2026
What is the Target Resting Heart Rate in Guidelines on Hypertension?Goran Koracevic, Milovan Stojanovic, Miloje Tomasevic, et al.
Current Vascular Pharmacology|January 24, 2025
Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular HypertrophyGoran Koracevic, Milovan Stojanovic, Marija Zdravkovic, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|August 31, 2022
A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart FailureGoran Koracevic, Zoran Perisic, Maja Stanojkovic, et al.
International Journal of Molecular Sciences|March 29, 2023
Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in FocusJelena Rakocevic, Milan Dobric, Rada Vucic, et al.
Pageof 3